Malignant Hypertension with Pulmonary Alveolar Hemorrhage Needing Dialysis
Author(s) -
Young-Hun Kim,
Ki Tae Bang,
Jong Ho Shin,
Ju Ri Kim,
Joo Heon Kim,
Jin Uk Jeong
Publication year - 2017
Publication title -
the ewha medical journal
Language(s) - English
Resource type - Journals
eISSN - 2234-2591
pISSN - 2234-3180
DOI - 10.12771/emj.2017.40.2.87
Subject(s) - medicine , hemodialysis , renal function , fibrinoid necrosis , pulmonary hemorrhage , renal biopsy , pathological , pulmonary hypertension , blood pressure , diffuse alveolar hemorrhage , dialysis , lung , cardiology , pathology , radiology , disease , vasculitis
Although blood pressure rises with age, it has been recognized that some individuals develop rapidly progressive blood pressure elevations with target organ injury. If these blood pressure elevations are not treated, the mortality rate in patients with target organ injury, including papilledema and declining kidney function, can exceed 50% over 6–12 months, and this hypertension is considered ‘malignant’ [1]. Malignant hypertension is histologically characterized by fibrinoid necrosis of arterioles and progresses rapidly. It is observed in a variety of organs, including the kidneys, pancreas, gastrointestinal tract, liver, retina, brain, myocardium, prostate, and skeletal muscles. However, pulmonary hemorrhage is rare. Here, we report a rare case of malignant hypertension with pulmonary alveolar hemorrhage. Case
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom